1. Home
  2. IQV vs EXC Comparison

IQV vs EXC Comparison

Compare IQV & EXC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IQV
  • EXC
  • Stock Information
  • Founded
  • IQV 1982
  • EXC 1999
  • Country
  • IQV United States
  • EXC United States
  • Employees
  • IQV 89000
  • EXC N/A
  • Industry
  • IQV Biotechnology: Commercial Physical & Biological Resarch
  • EXC Power Generation
  • Sector
  • IQV Health Care
  • EXC Utilities
  • Exchange
  • IQV Nasdaq
  • EXC Nasdaq
  • Market Cap
  • IQV 27.2B
  • EXC 44.1B
  • IPO Year
  • IQV 2013
  • EXC N/A
  • Fundamental
  • Price
  • IQV $164.24
  • EXC $43.13
  • Analyst Decision
  • IQV Buy
  • EXC Buy
  • Analyst Count
  • IQV 20
  • EXC 11
  • Target Price
  • IQV $226.80
  • EXC $47.64
  • AVG Volume (30 Days)
  • IQV 2.3M
  • EXC 6.1M
  • Earning Date
  • IQV 07-22-2025
  • EXC 07-31-2025
  • Dividend Yield
  • IQV N/A
  • EXC 3.71%
  • EPS Growth
  • IQV 0.26
  • EXC 15.84
  • EPS
  • IQV 7.35
  • EXC 2.69
  • Revenue
  • IQV $15,497,000,000.00
  • EXC $23,699,000,000.00
  • Revenue This Year
  • IQV $5.40
  • EXC $6.14
  • Revenue Next Year
  • IQV $5.20
  • EXC $2.75
  • P/E Ratio
  • IQV $22.36
  • EXC $16.03
  • Revenue Growth
  • IQV 2.84
  • EXC 6.72
  • 52 Week Low
  • IQV $134.65
  • EXC $34.01
  • 52 Week High
  • IQV $252.88
  • EXC $48.11
  • Technical
  • Relative Strength Index (RSI)
  • IQV 66.26
  • EXC 49.19
  • Support Level
  • IQV $155.15
  • EXC $42.54
  • Resistance Level
  • IQV $167.32
  • EXC $44.05
  • Average True Range (ATR)
  • IQV 4.12
  • EXC 0.62
  • MACD
  • IQV 0.73
  • EXC 0.12
  • Stochastic Oscillator
  • IQV 78.48
  • EXC 50.80

About IQV IQVIA Holdings Inc.

Iqvia is the result of the 2016 merger of Quintiles, a leading global contract research organization, and IMS Health, a leading healthcare data and analytics provider. The research and development segment focuses primarily on providing outsourced late-stage clinical trials for pharmaceutical, device, and diagnostic firms. The technology and analytics segment provides aggregated information and technology services to clients in the healthcare industry, including pharmaceutical companies, providers, payers, and policymakers, as well as data and analytics capabilities for clinical trials, including virtual trials. The company also has a small contract sales business.

About EXC Exelon Corporation

Exelon serves approximately 10 million power and gas customers at its six regulated utilities in Illinois, Pennsylvania, Maryland, New Jersey, Delaware, and Washington, D.C.

Share on Social Networks: